Prostate cancer

Clinical utility of a 1.5 T magnetic resonance imaging-guided linear accelerator during conventionally fractionated and hypofractionated prostate cancer radiotherapy. Front Oncol. 2022 Aug 16;12:909402. doi: 10.3389/fonc.2022.909402. PMID: 36052268; PMCID: PMC9424496.

Prostat brakiterapisi. Klinik etkinlik ve gelecek eğilimleri MedFiz online ekim-kasım 2019 sayı:23